In addition, recent literature reports support some of the predicted lncRNAs in the top 10 list; for example, the TRAF3IP2-AS1 lncRNA ranked second (No. 2) among our predictions and is a hub gene in a lncRNA-mediated ceRNA network that competes with the onco-lncRNAs, PVT1 and XIST, and could be a clinically relevant biomarker in glioblastoma (Zan and Li, 2019). Here, TRAF3IP2 is linked to glioblastoma.